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Abstract
Stress-induced hormones can alter the inflammatory response to tissue injury, however, the 
precise mechanism by which epinephrine influences inflammatory response and wound healing is 
not well defined. Here we demonstrate that epinephrine alters the neutrophil (PMN)-dependent 
inflammatory response to a cutaneous wound. Using non-invasive real-time imaging of 
genetically-tagged PMNs in a murine skin wound, chronic, epinephrine-mediated stress was 
modeled by sustained delivery of epinephrine. Prolonged systemic exposure of epinephrine 
resulted in persistent PMN trafficking to the wound site via an IL-6 mediated mechanism, and this 
in turn impaired wound repair. Further, we demonstrate that β2 adrenergic receptor-dependent 
activation of pro-inflammatory macrophages is critical for epinephrine-mediated IL-6 production. 
This study expands our current understanding of stress hormone-mediated impairment of wound 
healing and provides an important mechanistic link to explain how epinephrine stress exacerbates 
inflammation via increased number and lifetime of PMNs.
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Introduction
Impairment of skin wound healing results in chronic skin ulceration, a burgeoning clinical 
problem. Common etiologies include venous leg ulcers, diabetic foot ulcers, and pressure 
ulcers. While there are diverse pathologic processes at work in these different entities, one 
common effector pathway is believed to be persistent wound inflammation (Diegelmann and 
Evans, 2004; Liu et al., 2011) that is associated with prolongation of healing in venous, 
diabetic, and pressure ulcers (Gohel et al., 2008; Pradhan et al., 2009).
One recognized modulator of the inflammatory response is stress, either acute or chronic 
(Gouin et al., 2008; Viswanathan et al., 2005). Various types of stressors can activate either 
the hypothalamic-pituitary-adrenal axis or the sympathetic nerve system, resulting in the 
systemic release of stress hormones including glucocorticoids (GC) and catecholamines 
(Glaser and Kiecolt-Glaser, 2005; Webster et al., 2002). The systemic elevation of GC can 
attenuate the normal inflammatory and cellular immune responses to tissue injury and 
infection, and thereby impair wound healing (Hubner et al., 1996; Padgett et al., 1998). In 
contrast to the immune suppressive effects of GC, a large body of evidence supports the 
opposing action of stress-released catecholamines in augmenting the acute inflammatory 
response, especially when the response is in conjunction with tissue injury and infection 
(Bergmann and Sautner, 2002; Flierl et al., 2007). Catecholamines such as epinephrine can 
interact with all the cellular components of the immune system, since lymphocytes, 
macrophages, and neutrophils (PMNs) express α and β-adrenergic receptors (ARs) 
(Kavelaars, 2002; Kohm and Sanders, 2001). Systemic elevation of catecholamine is 
emblematic of most physiological stressors, including trauma, burn injury, and sepsis as well 
as chronic psychological stress (Engelman et al., 1983; Sivamani et al., 2009; Vanitallie, 
2002). Levels of circulating epinephrine can increase up to 10-fold in patients exposed to 
high stress during burn injury (Jeschke et al., 2011; Sedowofia et al., 1998). These elevated 
levels of epinephrine can result in enhanced release of pro-inflammatory cytokines including 
tumor necrosis factor-α (TNFα), interleukin (IL)-1β, and IL-6 (Frost et al., 2004; Johnson et 
al., 2005; Wong et al., 2012). Since these cytokines can recruit PMNs to the site of 
inflammation, their generation as a result of catecholamine stress could provide a link to the 
observed increase in PMN trafficking to the lung and liver of mice that have been 
challenged with high doses of epinephrine (Morken et al., 2002; von Montfort et al., 2008). 
Additionally, extraneuronal generation of epinephrine within the wound by PMNs 
themselves provides a potential for amplification of the catecholamine-mediated 
inflammatory response (Flierl et al., 2007). Despite recent advances in understanding of the 
role of epinephrine on inflammatory response and emerging evidence that stress impairs 
healing, the precise mechanism by which stress-induced epinephrine impacts upon the 
PMN-dependent innate immune response and contributes to wound chronicity is unclear.
Using an animal model to mimic chronic epinephrine-dependent stress, we examined how β2 
AR activation by epinephrine alters the kinetics of PMN trafficking to the site of a skin 
wound and its effect on the wound healing. These studies demonstrate that epinephrine-
stress promotes sustained PMN trafficking within the wound site. Further we provide 
evidence that IL-6 is the key proinflammatory cytokine that is critical for this epinephrine-
induced PMN wound trafficking and the resultant impairment of wound healing.
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Results
Epinephrine stress mediates persistent PMN trafficking into skin wounds and delays their 
healing
Chronic epinephrine-stress was emulated by the implantation of an osmotic pump that 
provided sustained delivery of epinephrine (5 mg/kg/day) or saline (control) immediately 
after skin wounding. The continuous delivery of epinephrine resulted in a 2-fold increase in 
plasma epinephrine levels compared to saline control at day 5 post-wounding (Fig. 1a), 
which is comparable to the value measured in a murine model of chronic isolation stress 
(Itoh et al., 2006). Mice that were exposed to this sustained levels of epinephrine exhibited 
delayed wound healing compared to control mice (saline-infused) (Figs.1b and 1c), or mice 
treated with a lower dose of epinephrine infusion (2.5 mg/kg/day) (Fig. S1). To investigate 
how increased levels of circulating epinephrine influence dynamics of PMN infiltration 
within the wound bed, whole animal fluorescence imaging of transgenic mice expressing the 
lysozyme-EGFP gene (EGFP-lys-mice) was employed. This model provides a linear EGFP 
signal with increased influx over time, in which >95% of the EGFPhigh cells were previously 
confirmed as mature PMNs (Kim et al., 2008). At day 2 post wounding, the extent of PMN 
recruitment was significantly augmented in the wounds of epinephrine-stressed mice and 
their increased trafficking to the wound persisted up to day 8 (Fig. 1d). This is in contrast to 
the gradual decline in wound PMNs observed in the control mice (Fig. 1d) or in the low 
dose epinephrine-stressed mice (Fig. S1), which paralleled the normal wound closure 
trajectory. The increased PMN trafficking to wounds of epinephrine-stressed mice was also 
confirmed by flow cytometric analysis of cells harvested from wounds at day 7. The number 
of Ly6G+ CD11b+ PMNs within the wounds of epinephrine-stressed mice was double that 
of control mice (Fig. 1e). Taken together, these data show that the extent and persistence of 
PMN recruitment is increased in mice that have elevated levels of plasma epinephrine, 
correlating with the observed delay in wound closure.
The persistence of wound PMN trafficking is responsible for epinephrine stress-mediated 
delayed healing
Since epinephrine-stressed mice exhibited both a marked increase in PMN trafficking to the 
wound and a delay in healing, we set out to determine whether these two observations were 
causally related. For this, mice were systemically depleted of PMNs with an anti-neutrophil 
monoclonal antibody (Gr-1) that was administered daily, beginning at day 1 post-wounding- 
the time point that PMN recruitment increased in response to epinephrine compared to saline 
infusion (Fig. 2a). When stressed with systemic elevation of epinephrine, the PMN-depleted 
mice had significantly attenuated numbers of EGFP-PMNs recruited to the wound at days 2 
through 8 as compared with mice treated with an IgG isotype control (Fig. 2b). Additionally, 
the antibody inhibition of PMN trafficking into the wound significantly increased the rate of 
wound closure for epinephrine-stressed mice (by 57%, p<0.05 vs epinephrine only), but the 
effect was negligible on saline-treated mice (Fig. 2c). These findings support the notion that 
persistent PMN trafficking contributes to the impaired wound healing observed in 
epinephrine-stressed mice.
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How might epinephrine stress lead to persistence of PMN numbers within the wound? A 
recent study has ascribed the persistent PMN trafficking observed in wounds in restraint-
stressed mice to an increase in wound bacterial burden (Tymen et al., 2012). This may be a 
function of the increase in cortisol levels or experimental conditions that is associated with 
the latter model (Campbell et al., 2001; Ridder et al., 2005). In our current study using 
epinephrine-stressed mice, a very low bacterial colony formation was detected with no 
significant difference between saline and epinephrine treatment (Fig. S2). Since PMN 
numbers in the peripheral circulation were comparable between epinephrine and saline 
control treated animals despite the remarkable difference in wound PMN trafficking (Fig. 
S3), we hypothesized that this persistence might be due to the capacity of PMNs infiltrating 
the wound to evade apoptosis and extend their survival. This was examined by an in vivo 
quantitation of the half-life of EGFP-labeled mature PMNs adoptively transferred and 
infiltrating the wound using a technique that we reported recently (Kim et al., 2011). Non-
proliferative mature EGFP-PMNs, defined as c-kit− EGFPhigh cells (1×107 cells), were 
isolated by FACS-sorting from bone marrow cells of EGFP-lys-mice and adoptively 
transferred by intravenous injection into C57BL/6 mice that were epinephrine-stressed or 
saline controls. Since the number of circulating EGFPhigh cells rapidly decrease to 
undetectable levels post infusion by day 2 (Fig. S4a), any observed EGFP-PMN 
fluorescence signal within the wound after this time point is contributed to prolonged 
survival of adoptively transferred PMNs that rapidly infiltrate the wound. Estimation of the 
half-life of EGFP-PMNs based on the rate of fluorescence signal decay (Fig.S4b) revealed 
that PMNs within wounds of epinephrine-stressed mice survived 2-fold longer than those in 
the saline treated controls (Fig. 2d; 4.23±0.05 days for epinephrine vs. 1.86±0.21 days for 
saline control; p<0.01). These data suggest that epinephrine promoted persistent PMN 
trafficking in the wound in part by prolonging the survival of the PMNs that infiltrated the 
wound environment.
Epinephrine stress-mediated PMN persistence and impaired wound healing is β2 AR 
dependent
The effects of epinephrine are mediated by their binding to subtypes of ARs, α1, α2, β1, β2, 
and β3 receptors, and their downstream signaling post- activation (Insel, 1996; Small et al., 
2003). Recent published data supports the potential role of β2 AR in wound healing, both by 
modulating the pro-inflammatory response (Rough et al., 2009; Tan et al., 2007) and 
impairing wound re-epithelialization (Sivamani et al., 2009). Hence, we examined whether 
epinephrine-stress induced PMN trafficking to wound sites and impaired wound healing was 
mediated by a β2AR-dependent mechanism. We therefore evaluated the role of β2AR-
dependent signaling on PMN trafficking and wound size using a pharmacological agonist 
(salbutamol) and antagonist (ICI 118,551) specific for the β2AR (Baker, 2005) in wounded 
EGFP-lys-mice. Treatment of mice with salbutamol (3 mg/kg/day) resulted in a delay in 
wound healing and prolonged trafficking of PMN to the wound, equivalent to that induced 
by epinephrine-stress (Figs.3a and 3b). On the other hand, treatment of epinephrine-stressed 
mice with the antagonist ICI 118,551 (0.7 mg/kg/day) remarkably attenuated PMN 
trafficking to the wound. This was also confirmed by flow cytometric analysis of Ly6G+ 
CD11b+ PMNs number harvested from wounds at day 7, in which ICI 118,551 treatment 
significantly reduced Ly6G+ CD11b+ PMNs within wounds down to the level of saline 
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control mice (Fig. S5). While the kinetics of wound closure were comparable in the 
epinephrine- and salbutamol-treated mice, treatment with the β2AR antagonist (ICI 118,551) 
significantly accelerated wound closure in epinephrine-treated mice at day 8, which is 
comparable to that of saline control mice (Fig. 3b). These findings suggest that that 
prolonged exposure to elevated levels of epinephrine results in persistent PMN presence in 
the wound site via β2AR-activation, which in turn delays wound repair.
IL-6 is a critical regulator of persistent PMN trafficking in local wounds of epinephrine-
treated mice
We next examined whether the epinephrine-stress mediated alterations in wound PMN 
trafficking correlated with altered expression of pro-inflammatory cytokines during the late 
phase of wound repair. Protein levels of IL-1β, TNF-α, IL-1α, IL-6 and GM-CSF were 
measured from tissue harvested from the wounded skin on day 5 post wounding using a 
multiplex cytokine assay. Wound tissue levels of IL-6 were substantially increased by 140% 
(Fig. 4a, p<0.05 vs saline), in the epinephrine treated animals, but protein levels of other 
proinflammatory cytokines (IL-1β, TNF-α, IL-1α, and GM-CSF) were not significantly 
altered as compared to the saline controls, despite their trend towards increase in tissue 
levels (Fig. S6).
This finding prompted us to investigate whether an increased tissue level of IL-6 mediated 
the persistent EGFP-PMN trafficking seen in the epinephrine-stressed wounds. To 
accomplish this, the local activity of IL-6 was blocked by the subcutaneous injection of an 
anti-IL-6 antibody (0.1 mg) into the wound bed, beginning on day 1 post-wounding, and 
continued every other day up to day 5 post-wounding (Fig. 4b). Indeed, the anti-IL-6 
antibody treatment significantly attenuated wound EGFP-PMN trafficking by 40% at day 8 
post-wounding in epinephrine-stressed mice (Epi-anti-IL-6) compared to animals treated 
with the isotype control (Epi-IgG) (Fig. 4c). Furthermore, the rate of wound closure in the 
epinephrine-stressed and anti-IL-6 treated mice was accelerated 2-fold compared to mice 
that received isotype control (Fig. 4d). Taken together, these data indicate that epinephrine 
upregulates IL-6 levels at the site of local skin wounding and this provides a critical signal 
to promote PMN persistence in the wound that results in delayed wound healing.
Epinephrine-stress mediates increased IL-6 expression in macrophages via β2 AR 
dependent mechanism
Macrophages within inflammatory wounds play an important role in generating a number of 
pro-inflammatory cytokines, including IL-6 (Stow et al., 2009). Given the crucial role of 
IL-6 in mediating epinephrine-stress in PMN wound trafficking, along with the observation 
that blockade of β2AR activation can reduce epinephrine-mediated PMN trafficking, we 
examined if epinephrine can stimulate enhanced IL-6 from naïve macrophage via β2AR 
activation. Treatment of macrophages with epinephrine (1 μM) resulted in ~3-fold increase 
in IL-6 production compared to untreated control (Fig. 5a). The epinephrine-induced 
production of IL-6 was blocked by the antagonist ICI 118,551 (1μM). We next sought in 
vivo evidence of whether wound macrophages were responsible for β2AR-dependent IL-6 
production in response to epinephrine. For this, F4/80+ macrophages were harvested from 
day 8 skin wounds in epinephrine-stressed mice (5 mg/kg/day) or epinephrine-stressed mice 
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treated with ICI 118,551 (0.7 mg/kg/day), and IL-6 gene expression was then determined 
using real-time qPCR analysis. Consistent with in vitro data of IL-6 ELISA (Fig. 5a), 
treatment of the epinephrine-stressed animals with ICI 118,551 (Epi+ICI) significantly 
attenuated IL-6 gene expression of F4/80+ macrophages by ~50% (p<0.05) (Fig. 5b). These 
data support a crucial role for wound-resident macrophages in producing IL-6 via β2AR 
activation in response to systemic elevations of epinephrine.
We next sought to determine whether sustained elevation of systemic levels of epinephrine 
alters the inflammatory phenotype of wound macrophages. We examined the surface 
expression of Ly6C in F4/80+ wound macrophages, as previous studies have reported that 
F4/80+ Ly6Chi macrophages exhibited a pro-inflammatory phenotype and cytotoxic 
activities, whereas F4/80+ Ly6Clo macrophages exhibit an anti-inflammatory phenotype and 
enhanced tissue repair activities (Arnold et al., 2007; Nahrendorf et al., 2007). The total 
number of F4/80+ macrophages was not different between Epi and Epi+ICI mice (Fig. S7). 
However, the number of pro-inflammatory F4/80+ Ly6Chi cells was significantly decreased 
by ~40% in the β2AR antagonist treated animals (Epi+ICI, Fig. 5c). This data suggests that 
the epinephrine-stress mediated activation of β2AR signaling contributes to the increased 
trafficking or local differentiation of the proinflammatory macrophage within wounds, 
which then results in persistent inflammation and delayed wound healing.
Discussion
Using a pharmacologic stress paradigm, we demonstrate that prolonged systemic exposure 
of epinephrine results in persistent PMN trafficking and prolonged survival within the 
wound site via β2AR-dependent and IL-6-mediated mechanisms and this in turn impairs 
wound repair. This study expands our current understanding of stress-mediated impairment 
of wound healing and provides a pivotal insight into the mechanism by which epinephrine 
stress exacerbates inflammation and impairs wound healing.
There is significant clinical evidence linking chronic stress to the exacerbation of many 
disease processes in the immunologic, neoplastic and cardiovascular realms (Hassan et al., 
2013; Wong et al., 2012). Recent work has expanded this link to wound healing, wherein 
chronic stress is associated with delayed healing in both experimental and clinical scenarios 
(Kiecolt-Glaser et al., 1995; Walburn et al., 2009). Here, we focused on the catecholamine 
epinephrine, whose elevation parallels both acute and chronic stress, and explored 
hypothesis that stress-induced epinephrine contributes to impairment of healing via 
immunomodulation of the wound environment. In support of this, we demonstrated that 
systemically elevated epinephrine superimposed upon skin injury resulted in impaired 
wound healing by prolongation of wound inflammation that led to persistent PMN 
trafficking. Epinephrine stress may impair healing by multiple, overlapping mechanisms. 
Our recent study demonstrating the direct role of epinephrine in inhibiting keratinocyte 
motility and re-epithelialization is one way that epinephrine stress impairs healing (Sivamani 
et al., 2009). This study unveils another mechanism by which epinephrine contributes to 
impairment of wound healing by promoting a PMN-dependent inflammatory response.
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Previous studies have demonstrated systemic increases in plasma IL-6 levels in response to 
diverse stressors including long-term caregiving (Kiecolt-Glaser et al., 2003), burn injury 
(Kawakami et al., 2001), psychological stress (Takaki et al., 1994), and childhood 
maltreatment stress (Carpenter et al., 2010). Here we demonstrate a stress-mediated increase 
in IL-6 localized to the wound niche. Our findings that the local blockade of IL-6 activity 
with anti-IL-6 antibody could attenuate wound PMN trafficking and improve wound healing 
strongly supports the notion that IL-6 is a critical signal linking epinephrine effects with 
persistent PMN trafficking. IL-6 can promote tissue PMN trafficking during the 
inflammatory response via selective regulation of inflammatory chemokines or mediating 
anti-apoptotic events. Multiple lines of evidence support a relationship between increased 
IL-6 level and prolonged lifetime of PMNs (Asensi et al., 2004; Daffern et al., 1999; 
Ottonello et al., 2002), which is consistent with our observation of extended survival of 
PMNs in wounds under epinephrine stress.
Another important finding from this study was that epinephrine-mediated β2AR activation 
primed wound-associated macrophages into a pro-inflammatory profile, and this, in turn, 
was responsible for amplified IL-6 production and persistent PMN trafficking. This 
conclusion is supported by experiments using a β2AR -specific pharmacological antagonist 
to inhibit epinephrine-mediated responses. We found that blockade of β2AR signaling 
significantly (1) attenuates epinephrine-mediated trafficking of the pro-inflammatory 
phenotype of macrophages (F4/80+Ly6Chi macrophages), (2) attenuates epinephrine-
induced IL-6 gene expression from wound-isolated macrophages, and (3) attenuates 
epinephrine-mediated wound PMN trafficking. Macrophages demonstrate considerable 
plasticity in adjusting their phenotype in response to environmental cues (Mosser and 
Edwards, 2008). Interestingly, repeated psychosocial stress can increase the number of 
Ly6Chi macrophages that traffic to inflamed tissue in the brain, and chronic restraint stress 
similarly increases the trafficking of this pro-inflammatory macrophage phenotype to breast 
cancer tumors, with both of these responses blocked by an β-AR antagonist (Wohleb et al., 
2011). Additionally, the role of β2AR signaling in modulating immunological responses has 
been supported by the demonstration that its activation enhances pro-inflammatory 
cytokines and, conversely, by the efficacy of β2AR blockade in attenuating the inflammatory 
responses in various pathological conditions including traumatic injury, burn injury, and 
sepsis (Rough et al., 2009). Our findings are consistent with previous demonstrations of 
induction of a pro-inflammatory profile of macrophages by β2AR activation, and extend 
those findings by revealing a stress/epinephrine-mediated activation of β2AR signaling 
pathway that can alter IL-6 cytokine expression in macrophages in the wound, which drive 
persistent PMN trafficking. Additionally, it is conceivable that macrophages might be 
pivotal regulators in the epinephrine-mediated pro-inflammatory response, not only for 
PMN trafficking but also for other significant aspects of wound repair, given the observation 
that the inhibition of PMN infiltration with either anti-Gr1 or anti-IL-6 antibody treatment 
resulted in partial recovery of optimal wound healing while the blockade of β2AR signaling 
fully recovered wound closure in the epinephrine-treated mice (Fig. 3b).
In summary, this study reveals a role of epinephrine in promoting persistent inflammation in 
skin wounds and demonstrates the pivotal mechanistic role played by β2AR-dependent IL-6 
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production in the persistent PMN trafficking to the wound (Fig. S8). Since sustained 
elevation of systemic epinephrine has been associated with different stress etiologies, such 
as trauma, burn injury, and sepsis (Engelman et al., 1983; Sivamani et al., 2009; Vanitallie, 
2002), targeting the β2AR-dependent signaling pathway in these stressed patients may 
provide a clinically effective immunomodulatory therapeutic strategy to normalize 
macrophage phenotype, optimize the number of PMNs and thereby avoid prolonged 
inflammation in cutaneous wounds.
Materials and Methods
Mice
Female EGFP-lysozyme M (lys) knock in-mice (EGFP-lys-mice) backcrossed onto 
C57BL/6 at least 8 generations (Faust et al., 2000) (kind gift from Dr. Thomas Graf) and 
C57BL/6 mice (Jackson laboratory) were used in the experiments. Further details are 
provided in Supplementary Materials and Methods.
Mouse model of skin wounding and osmotic pump implantation
Mouse skin wounding and osmotic pump implantation were performed as described 
previously (Kim et al., 2011; Kim et al., 2008; Sivamani et al., 2009). Briefly, a circular full 
thickness wound (6mm in diameter) was made on the back skin of mouse using a skin 
biopsy punch (Robbins instruments Inc., NJ). Immediately after skin wounding, while the 
mouse is still anesthetized, an osmotic minipump (1002 model, Alzet, Durect Corporation, 
Cupertino, CA) was implanted subcutaneously in the side flank. Further details are provided 
in Supplementary Materials and Methods.
Non-invasive quantification of wound EGFP-PMNs trafficking
The trafficking of EGFP-PMNs at wound sites over time was determined non-invasively 
using the IVIS 100 imaging system (Caliper Life Sciences, Inc. MA) as described previously 
(Kim et al., 2008) and in the Supplementary Materials and Methods.
Flow cytometric immunophenotyping of wound PMNs and macrophages
At seleted time points post-wounding, skin wounds were harvested from C57BL/6 mice 
treated with saline, epinephrine (5 mg/kg/day) or epinephrine with β2AR antagonist ICI 
118,551 (0.7 mg/kg/day) and the immunophenotyping of wound PMNs and macrophages 
were performed as described in Supplementary Materials and Methods.
Immuno-depletion of systemic PMNs
Systemic PMNs were depleted by multiple injections (i.p) of anti-Gr-1 monoclonal antibody 
(0.1 mg each injection, RB6-8C5 clone, eBioscience, CA) or isotype control IgG 
(eBioscience, CA) every other day, starting day 1 post-wounding up to day 5.
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Plasma epinephrine measurement
Plasma epinephrine measurements were performed using enzyme immunoassay kit 
(Epinephrine ELISA kit, Rocky mountain diagnostics, Inc., CO) as described in 
Supplementary Materials and Methods.
The quantification of PMN half-life in the wound
The quantification of PMN half-life in the wound was performed as described previously 
(Kim et al., 2011) and in the Supplementary Materials and Methods.
Multiplex cytokine assay from wounded skin
The proinflammatory cytokine levels in the wounded skin were measured using 
MILLIPLEX MAP 13-plex Cytokine Kit (Millipore, Billerica, MA) as described in the 
Supplementary Materials and Methods.
Anti-IL-6 antibody treatment of murine wounds
Monoclonal mouse anti-IL-6 antibody (clone MP520F3, R&D System, MN) or isotype 
control, IgG1 (R&D system, MN) was subcutaneously injected into the periphery of the 
wound bed (0.1 mg each injection) every other day, starting 24hr after wounding up to day 
5.
IL-6 ELISA assay from mouse macrophage
IL-6 ELISA from mouse macrophages was performed as described in the Supplementary 
Material and Methods.
Real time-qPCR for IL-6 gene expression from wound macrophages
Real-time quantitative PCR analysis for the IL-6 gene was performed using macrophages 
isolated from wounds of EGFP-lys-mice treated with either epinephrine (5 mg/kg/day) or 
epinephrine with β2AR antagonist ICI 118,551 (0.7 mg/kg/day) at day 8 post-wounding and 
detailed experimental procedure was described in the Supplementary Materials and 
Methods.
Statistical analysis
Data analysis was performed using GraphPad Prism version 5.0 software (GraphPad 
Software, San Diego, CA). Statistical significance between two groups was determined by 
two-tailed unpaired t tests. Statistical signficance among multiple groups were analyzed 
using the one-way ANOVA followed by the Turkey post-test for secondary analysis for 
significance. P values of <0.05 were considered statistically significant. Data are expressed 
as mean ± SEM.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Effects of epinephrine on wound PMN trafficking and wound healing
EGFP-lys-mice (a-d) and C57BL6 wild-type mice (e) were systemically delivered with 
sterile saline or epinephrine (5 mg/kg/day). (a) Plasma epinephrine levels were measured at 
day 5 post-wounding. (b) Kinetics of wound closure and representative wound images. (c) 
Wound re-epithelialization measured from histological sections collected at day 8 post-
wounding. Red-line indicates a re-epithelialized region. (d) Kinetics of wound EGFP-PMN 
fluorescence and representative images. (e) Wound PMN (CD11b+Ly6G+ cell) numbers 
were quantified by flow cytometric analysis of cells harvested from wounded skin of mice 
treated with either saline or epinephrine at day 7 post-wounding. Representative FACS plot 
(left panel) and quantification (right panel). n=6-8 mice in each group. *, p<0.05 vs Saline 
group.
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Figure 2. The persistence of wound PMN trafficking is responsible for epinephrine stress-
mediated delayed healing
(a) Experimental design for delayed depletion of systemic EGFP-PMNs. Systemic PMNs 
were depleted with anti-neutrophil antibody (Gr-1 mAb) treatment from saline-treated 
(Saline+Gr-1) and epinephrine-treated EGFP-lys-mice (5 mg/kg/day, Epi+Gr-1). Kinetics of 
wound EGFP-PMNs (b) and wound closure (c) were determined and results were compared 
with mice that received with isotype control (Saline+IgG or Epi+IgG). n=5-6 mice in each 
group. #, p<0.05 between Saline+IgG vs Saline+Gr-1 and *, p<0.05 between Epi+IgG vs 
Epi+Gr-1. (d) Calculation of the half-life of PMNs infiltrating wound based on the rate of 
EGFP-fluorescence signal decay (see Methods and Fig. S4). n=3-4 mice in each group. ##, 
p<0.05 vs Saline control.
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Figure 3. Effects of β2AR blockade on epinephrine-mediated PMN recruitment and wound 
closure
Kinetics of wound EGFP-PMN trafficking (a) and wound closure (b) from EGFP-lys-mice 
treated with saline, β2AR agonist (salbutamol, 3 mg/kg/day), epinephrine (5 mg/kg/day), and 
epinephrine with β2AR antagonist (ICI 118,551, 0.7 mg/kg/day). n=5-6 mice in each group. 
*, p<0.05 between Saline vs Epi group and #, p<0.05 between Epi vs Epi+ICI group.
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Fig. 4. IL-6 is a critical regulator of persistent PMN trafficking in local wounds of epinephrine-
treated mice
(a) IL-6 protein level in the wound. Wounded skin samples were harvested from EGFP-lys-
mice treated with either saline or epinephrine (5 mg/kg/day) at day 5 post wounding and 
protein levels of IL-6 were measured. (b) Experimental design for anti-IL-6 antibody 
treatment into the wounds of mice. Either anti-IL-6 antibody or isotype control was 
subcutaneously injected into the periphery of wound bed of epinephrine-treated EGFP-lys-
mice (5 mg/kg/day) every other day, starting 24hr after wounding up to day 5. Kinetics of 
wound EGFP-PMNs (c) and wound closure (d) were determined. n=4-5 mice in each group. 
#, p<0.05 vs Saline group and *, p<0.05 vs Epi+IgG group.
Kim et al. Page 16
J Invest Dermatol. Author manuscript; available in PMC 2014 September 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Fig.5. Epinephrine mediates increased IL-6 expression in wound macrophages via β2 AR-
dependent mechanism
(a) Macrophage production of IL-6 in response to epinephrine (1 μM) or epinephrine with 
ICI 118,551(1 μM). IL-6 production was quantified by ELISA assay. (b) Gene expressions 
of IL-6 in macrophages isolated from wounds of mice treated either epinephrine or 
epinephrine with ICI 118,551 at day 8 post-wounding. β2 macroglobulin was used for 
reference gene. (c) The effect of β2AR antagonist on epinephrine-mediated F4/80+Ly6Ghi 
cells trafficking in wounds. Cells were harvested from wounds of mice treated with 
epinephrine (5 mg/kg/day) or epinephrine with ICI 118,551 (0.7 mg/kg/day) at day 8 and 
were analyzed using flow cytometry. n=4-5 mice in each group. *, p<0.05 between Epi vs 
Epi+ICI and #, p<0.05 between Epi vs Saline.
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